Bio-Techne (TECH) Revenue & Quarterly History
Explore Bio-Techne Corporation (TECH) revenue from 2023 through the latest reported quarter, with SEC-sourced comparisons and filing-constrained analysis.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q3
Revenue for the quarter declined compared to the same quarter last year. Sequentially, revenue increased from the immediately preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$311.4M
Revenue reported for this quarter.
Quarter-over-quarter
+5.3%
Change from the immediately preceding quarter.
Year-over-year
-1.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $317M | +3.5% |
| Sep 30, 2025 | $286.6M | -1.0% |
| Dec 31, 2025 | $295.9M | -0.4% |
| Mar 31, 2026 | $311.4M | -1.5% |
Revenue performance
The reported revenue decreased relative to the same quarter one year earlier. The sequential comparison shows a recovery from the prior quarter's level.
Quarterly comparison
Compared with the immediately preceding quarter, revenue rose. However, when measured against the same quarter one year ago, revenue was lower.
What to watch
The company faces a future obligation to acquire the remaining interest in Wilson Wolf, with a forecasted payment between fiscal 2026 and fiscal 2028.